CSE/VENI (CSE/VENI)

Canadian Securities Exchange: CSE/VENI · CAD

CA$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	1.1M
Revenue (ttm)	2.6M
Net income (ttm)	-1.8M
EPS (ttm)	-CA$0.01
Shares out	222.6M
Volume	2,000
Beta	0.88

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.6M
Net income (ttm): -1.8M
EPS (ttm): -CA$0.01
Market cap: 1.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROE-165.6

P25 -104.1P50 -30P75 6.7

ROIC-40.8

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All CSE/VENI indicators

Market & fundamental data

Available fields

134

Groups with data

Currency

USD

Showing 134 of 134 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Enterprise value	CAD -1.9M
Exchange	Canadian Securities Exchange
Financial currency	USD
Financial report date	2026-04-30
First seen	2026-05-10
Fiscal year end	April
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA92260V1031
Last earnings date	2024-12-27
Last refreshed	2026-10-29
Market cap	CAD 1.1M
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
SIC code	6720
Stock price date	2026-10-01
Symbol	cse/VENI
Website	https://vencanna.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-161.28%
FCF / EV yield	30.87%
FCF yield	-53.39%
Industry forward P/E	34.4x
P/B ratio	4.37x
P/S ratio	0.43x
Price / tangible book value	0.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-74.5%
EBITDA margin	-72.18%
Gross margin	-18.95%
Operating margin	-74.5%
Pretax margin	-93.54%
Profit margin	-70.15%
ROA	-23.24%
ROCE	-363.74%
ROE	-165.65%
ROIC	-40.76%
Tax / revenue	4.52%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	4
EPS growth years	1
Net income growth quarters	4
Net income growth years	1
Revenue growth	-53.15%
Revenue growth (Q)	-22.85%
Revenue growth (QoQ)	17.07%
Revenue growth 3Y	-48.96%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -102,539
Depreciation and amortization	CAD 61,162
EBIT	CAD -1.9M
EBITDA	CAD -1.8M
EPS	CAD -0.01
FCF per share	CAD -0.00
Financing cash flow	CAD -168,546
Free cash flow	CAD -594,352
Gross profit	CAD -485,097
Income taxes	CAD 115,704
Investing cash flow	CAD -102,539
Net borrowing	CAD -173,242
Net cash flow	CAD -766,581
Net income	CAD -1.8M
Operating income	CAD -1.9M
Revenue	CAD 2.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-17.71
Book value per share	CAD 0.01
Debt / equity	0
Interest coverage	-7.04
Long-term assets	CAD 1.5M
Long-term liabilities	CAD 211,185
Net cash (debt)	CAD 47,722
Net cash / market cap	4.29%
Net debt / equity	-0.19
Piotroski F-Score	2
Property, plant and equipment	CAD 1.3M
Shareholders' equity	CAD 254,722
Tangible book value	CAD 3M
Tangible book value per share	CAD 0.01
Total assets	CAD 2.6M
Total cash	CAD 47,722
Total debt	CAD 0
Total liabilities	CAD 2.4M
WACC	9.11%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.5
Current assets	CAD 1.1M
Current liabilities	CAD 2.2M
Current ratio	0.5
Inventory turnover	5.23
Net working capital	CAD -1.1M
Quick ratio	0.25
Working capital	CAD -1M
Working capital turnover	-5.5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%
20-day SMA	CAD 0.01
50-day SMA	CAD 0.01
52-week high	CAD 0.01
52-week high date	2026-07-14
52-week low	CAD 0.01
52-week low date	2026-10-01
All-time high	CAD 0.03
All-time high date	2024-05-28
All-time low	CAD 0.01
All-time low date	2024-09-05
Average true range (ATR)	CAD 0.00
Average volume	83.9K
Beta (1Y)	1.55
Beta (2Y)	0.36
Beta (5Y)	0.88
Change from 52-week high	-50%
Change from 52-week low	0%
Change from all-time high	-83.33%
Change from all-time low	0%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 10
High price	CAD 0.01
Low price	CAD 0.01
Monthly RSI	21.35
Open price	CAD 0.01
Previous close	CAD 0.01
Price vs 20-day SMA	-13.79%
Price vs 50-day SMA	-25.37%
Relative volume	0.02
RSI	42.43
Sharpe ratio	1.94
Sortino ratio	4.16
Volume	2K
Weekly RSI	37.38

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	173.5M
Shares change (QoQ)	0%
Shares held by insiders	22.07%
Shares outstanding	222.6M

Deeper analysis on CSE/VENI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/VENI report

Is a complete CSE/VENI research report available?

No complete published report is available for cse/VENI (CSE/VENI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/VENI (CSE/VENI)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/VENI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/VENI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on CSE/VENI

Frequently asked questions